InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: sox040713 post# 223590

Sunday, 04/08/2018 7:44:36 PM

Sunday, April 08, 2018 7:44:36 PM

Post# of 403217
I never said that but I am questioning the value of K in negotiation as it is like in P1 - when Biogene, Pfizer, NVS has other products in advance stages - so will any BP even try to consider K for development? Unlikely

Didn’t same logic was put forward for B-ABSSI shelving P3? It was said that with so many ABSSI drugs now approved, it is better to move to other areas as ABSSI will not fetch much value
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News